Argenica Therapeutics Ltd (AU:AGN) has released an update.
Argenica Therapeutics Limited, identified by ASX issuer code AGN, has announced the application for quotation of 589,041 new fully paid ordinary securities on June 14, 2024. This move indicates a potential expansion or fundraising effort by the company, which could be of interest to current and prospective investors.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
